74 related articles for article (PubMed ID: 2291876)
1. Pharmacokinetics of CGP 6140 (amocarzine) after oral administration of single 100-1600 mg doses to patients with onchocerciasis.
Lecaillon JB; Dubois JP; Awadzi K; Poltera AA; Ginger CD
Br J Clin Pharmacol; 1990 Oct; 30(4):625-8. PubMed ID: 2291876
[TBL] [Abstract][Full Text] [Related]
2. The influence of food on the pharmacokinetics of CGP 6140 (amocarzine) after oral administration of a 1200 mg single dose to patients with onchocerciasis.
Lecaillon JB; Dubois JP; Soula G; Pichard E; Poltera AA; Ginger CD
Br J Clin Pharmacol; 1990 Oct; 30(4):629-33. PubMed ID: 2291877
[TBL] [Abstract][Full Text] [Related]
3. Influence of food related to dose on the pharmacokinetics of amocarzine and of its N-oxide metabolite, CGP 13 231, after oral administration to 20 onchocerciasis male patients from Guatemala.
Lecaillon JB; Poltera AA; Zea-Flores G; de Ramirez I; Nowell de Arevalo A
Trop Med Parasitol; 1991 Sep; 42(3):286-90. PubMed ID: 1801154
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of amocarzine in plasma of 71 Ecuadorian patients of two different races receiving 3 mg/kg b.i.d. and 5 mg/kg o.d. oral postprandial doses for 3 days.
Lecaillon JB; Godbillon J; Guderian R; Guevara A; Cascante S; Poltera AA
Trop Med Parasitol; 1991 Sep; 42(3):291-3. PubMed ID: 1801155
[TBL] [Abstract][Full Text] [Related]
5. Onchocercacidal effect of three drug regimens of amocarzine in 148 patients of two races and both sexes from Esmeraldas, Ecuador.
Guderian RH; Anselmi M; Proaño R; Naranjo A; Poltera AA; Moran M; Lecaillon JB; Zak F; Cascante S
Trop Med Parasitol; 1991 Sep; 42(3):263-85. PubMed ID: 1801153
[TBL] [Abstract][Full Text] [Related]
6. Amocarzine investigated as oral onchocercacidal drug in 272 adult male patients from Guatemala. Results from three dose regimens spread over three days.
Zea-Flores G; Beltranena F; Poltera AA; Lopez M; Moran M; Zea-Flores CE; de Ramirez I; Lecaillon JB; Zak F; Palomo M
Trop Med Parasitol; 1991 Sep; 42(3):240-62. PubMed ID: 1801152
[TBL] [Abstract][Full Text] [Related]
7. Onchocercacidal effects of amocarzine (CGP 6140) in Latin America.
Poltera AA; Zea-Flores G; Guderian R; Beltranena F; Proana R; Moran M; Zak F; Striebel HP
Lancet; 1991 Mar; 337(8741):583-4. PubMed ID: 1671945
[TBL] [Abstract][Full Text] [Related]
8. Fine structure of microfilariae in the skin of onchocerciasis patients after exposure to amocarzine.
Büttner G; Zea-Flores G; Poltera AA; Büttner DW
Trop Med Parasitol; 1991 Sep; 42(3):314-8. PubMed ID: 1801159
[TBL] [Abstract][Full Text] [Related]
9. Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus.
Baraka OZ; Mahmoud BM; Marschke CK; Geary TG; Homeida MM; Williams JF
Eur J Clin Pharmacol; 1996; 50(5):407-10. PubMed ID: 8839664
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
Menon-Andersen D; Mondick JT; Jayaraman B; Thompson PA; Blaney SM; Bernstein M; Bond M; Champagne M; Fossler MJ; Barrett JS
Cancer Chemother Pharmacol; 2009 Jan; 63(2):229-38. PubMed ID: 18398615
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of implanted male Onchocerca gibsoni in mice as a screen for macrofilaricides against Onchocerca volvulus.
Vankan DM; Copeman DB; Novak M
Trop Med Parasitol; 1988 Dec; 39 Suppl 4():472-4. PubMed ID: 3227248
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of centperazine: a new antifilarial agent.
Agarwal N; Sharma S; Srivastava VM
Int J Clin Pharmacol Res; 1988; 8(4):231-7. PubMed ID: 3182112
[TBL] [Abstract][Full Text] [Related]
13. Longterm follow-up of onchocerciasis patients in Latin America after treatment and retreatment with amocarzine. Preliminary results.
Poltera AA; Zea-Flores G; Guderian R; Striebel HP; Moran M
Trop Med Parasitol; 1991 Sep; 42(3):308-13. PubMed ID: 1801158
[TBL] [Abstract][Full Text] [Related]
14. Microfilaricidal effect of amocarzine in skin punch biopsies of patients with onchocerciasis from Latin America.
Zak F; Guderian R; Zea-Flores G; Guevara A; Moran M; Poltera AA
Trop Med Parasitol; 1991 Sep; 42(3):294-302. PubMed ID: 1801156
[TBL] [Abstract][Full Text] [Related]
15. Use of an ophthalmologic ultrasoundscanner in human onchocercal skin nodules for non-invasive sequential assessment during a macrofilaricidal trial with amocarzine in Guatemala. The first experiences.
Poltera AA; Reyna O; Zea-Flores G; Beltranena F; Nowell de Arevalo A; Zak F
Trop Med Parasitol; 1991 Sep; 42(3):303-7. PubMed ID: 1801157
[TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatographic determination of oxatomide and its metabolite and its application to pharmacokinetic study in rat plasma.
Kikuchi K; Ohishi T; Masuike T; Ohmori K; Sakai K
Arzneimittelforschung; 2002; 52(10):754-63. PubMed ID: 12442638
[TBL] [Abstract][Full Text] [Related]
17. The use of monoclonal antibody-based ELISAs to monitor chemotherapeutic effects in the bovine-Onchocerca gibsoni drug screen.
More SJ; Copeman DB
Trop Med Parasitol; 1991 Mar; 42(1):17-20. PubMed ID: 2052850
[TBL] [Abstract][Full Text] [Related]
18. Studies on the activity of the Ciba Geigy compounds CGP 6140, 20376, 20309 and 21833 against third and fourth stage larvae of Onchocerca volvulus.
Strote G
Trop Med Parasitol; 1989 Mar; 40(1):51-6. PubMed ID: 2740728
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of suramin, ivermectin and CGP 20376 in a new macrofilaricidal drug screen, Onchocerca ochengi in African cattle.
Renz A; Trees AJ; Achu-Kwi D; Edwards G; Wahl G
Trop Med Parasitol; 1995 Mar; 46(1):31-7. PubMed ID: 7631125
[TBL] [Abstract][Full Text] [Related]
20. The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus.
Awadzi K; Edwards G; Duke BO; Opoku NO; Attah SK; Addy ET; Ardrey AE; Quartey BT
Ann Trop Med Parasitol; 2003 Mar; 97(2):165-78. PubMed ID: 12803872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
